Trial Condition(s):
Vaginitis
Study to evaluate the efficacy, safety and acceptance of a once a day application of a vaginal ovule or vaginal cream containing different active ingredients in patients with candidal, bacterial, trichomonal or mixed vaginitis
Bayer Identifier:
91148
ClinicalTrials.gov Identifier:
Not Available
EudraCT Number:
Not Available
EU CT Number:
Not Available
Trial Purpose
Please see attached Study Results Summary below.
Inclusion Criteria
No Inclusion Criteria Available
Exclusion Criteria
No Exclusion Criteria Available
Trial Summary
Enrollment Goal
Trial Dates
Phase
Could I receive a placebo?
Products
Accepts Healthy Volunteers
Where to Participate
| Locations |
|---|
Trial Design
Comparative, open, randomized, reference controlled study to evaluate the efficacy, safety and acceptance of a once a day application of a vaginal ovule SH AR 1570 or vaginal cream SH AR 1580 containing metronidazole 750 mg and miconazole nitrate 200 mg (each ovule/vaginal cream dose) for 7 days vs. Vaginal ovule containing tinidazole 150 mg and miconazole nitrate 400 mg each ovule for 8 days or vaginal cream, containing tinidazole 150 mg and miconazole nitrate 100 mg each vaginal cream dose for 7 days in 400 patients with candidal, bacterial, trichomonal or mixed vaginitis
Trial Type:
Interventional
Intervention Type:
N/A
Trial Purpose:
N/A
Allocation:
N/A
Blinding:
N/A
Assignment:
N/A
Trial Arms:
N/A
Primary Outcome
- Timeframe:
Secondary Outcome
- Timeframe:
Additional Information
Copyright © Bayer
Powered by
